Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Innerworkings Inc (INWK): Sagard Capital Sells Off Its Large Stake

Page 1 of 6

Dan Friedberg‘s Sagard Capital Partners Management Corp reported dumping its entire stake in Innerworkings Inc (NASDAQ:INWK) via an amended 13D filing with the Securities and Exchange Commission. According to the filing, the fund doesn’t own any shares of the company in which it previously held 7.16 million shares, which accounted for 13.1% of the company’s outstanding stock. Dan Friedberg was a Director of Innerworkings Inc (NASDAQ:INWK), but resigned from his position on August 15.

Innerworkings is a global marketing executions company that provides its professional services to Fortune 500 brands covering a variety of industries, which operates in three divisions: Latin America, North America, and EMEA. Over the past 12 months, the company’s stock is up by 19.22%. For the second quarter of 2016, Interworkings disclosed non-GAAP diluted earnings per share of $0.11 and revenue of $269.2 million, topping the estimates $0.04 and $265.1 million respectively.

stock, exchange, trade, ipo, market, london, share, rate, sales, price, new, york, profit, index, broker, chart, rising, falling, street, frankfurt, wall, world, cash, points, display,

lassedesignen/Shutterstock.com

According to Insider Monkey’s database, there was no change in the number of hedge fund positions in Innerworkings (NASDAQ:INWK) in the second quarter, among those in our database, as 11 investors were long the stock at the end of June. Among them were Jim Simons’ Renaissance Technologies, which held a position worth around $2.77 million, Chuck Royce’s Royce & Associates, with a position valued at $943,000, and Ken Griffin’s Citadel Investment Group. Peter Algert and Kevin Coldiron’s Algert Coldiron Investors initiated a new position in the company during the quarter, worth $170,000 at the end of June.

Follow Innerworkings Inc (NASDAQ:INWK)
Trade (NASDAQ:INWK) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sagard Capital Partners 0 0 0 0 0
Sagard Capital Partners GP, Inc 0 0 0 0 0
Sagard Capital Partners Management Corp 0 0 0 0 0
Dan Friedberg
Dan Friedberg
Sagard Capital Partners Management Corp

Page 1 of 6 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 7)*

Innerworkings, Inc.
(Name of Issuer)

Common Stock, par value $0.0001 per share
(Title Class of Securities)

45773Y105
(CUSIP Number)

Samuel Robinson
Sagard Capital Partners, L.P.
325 Greenwich Avenue
Greenwich, CT 06830
(203) 629-6700

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

September 8, 2016
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [   ].

NOTE:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Page 1 of 6

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!